Article
Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis.
Tuberculosis (Edinburgh, Scotland) - 1 Jul 2024
Sharma Kusum, Sharma Megha, Shree Ritu, Singla Neeraj, Joshi Himanshu, Modi Tanish, Goyal Manoj, Sharma Aman, Sharma Navneet, Modi Manish
Abstract excerpt
SETTING AND OBJECTIVE: To develop and evaluate newer molecular tests that identify drug resistance according to contemporary definitions in Tuberculous meningitis (TBM), the most severe form of EPTB. DESIGN: 93 cerebrospinal fluid (CSF) specimens [41 culture-positive and 52 culture-negative], were subjected to Truenat MTB Plus assay along with chips for rifampicin, isoniazid, fluoroquinolones and bedaquiline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
